anonymous
Guest
anonymous
Guest
US House report slams AbbVie for inflating prices on Humira, Imbruvica.
All the price increases on Humira and patent protections will now result with a oversight committee hearing on Tuesday, lawmakers have sent a letter asking the Federal Trade Commission (FTC) to conduct a formal inquiry into whether AbbVie's practices broke the law.
All the price increases on Humira and patent protections will now result with a oversight committee hearing on Tuesday, lawmakers have sent a letter asking the Federal Trade Commission (FTC) to conduct a formal inquiry into whether AbbVie's practices broke the law.